Dinaciclib (SCH 727965) Is a Novel Cyclin-Dependent Kinase (CDK) Inhibitor That Exhibits Activity In Patients With Relapsed Or Refractory Chronic Lymphocytic Leukemia (CLL) - Flynn, Joseph M.M.; Andritsos, Leslie A.; Jones, Jeffrey A.; Johnson, Amy J.; Maddocks, Kami; Wiley, Elizabeth; Small, Karen; Im, Eun Kyung; Grever, Michael R.; Bannerji, Rajat; Byrd, John C.; Zhou, Honghong (Blood, 2013)